LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis → Does this make you sick? (From Allegiance Gold) (Ad) Free PRTC Stock Alerts GBX 226.50 -2.00 (-0.88%) (As of 03:15 PM ET) Add Compare Share Share Today's Range 224.50▼ 23250-Day Range 195.60▼ 22952-Week Range 139▼ 242.93Volume179,417 shsAverage Volume387,255 shsMarket Capitalization£612.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get PureTech Health alerts: Email Address Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. About PureTech Health Stock (LON:PRTC)PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesMay 17, 2024 | americanbankingnews.comPureTech Health (LON:PRTC) Stock Passes Above 50-Day Moving Average of $215.04April 9, 2024 | markets.businessinsider.comPureTech Names Bharatt Chowrira CEO As Daphne Zohar Turns CEO Of Newly Launched Seaport TherapeuticsApril 2, 2024 | msn.comHere’s one FTSE 250 stock I’d buy in AprilMarch 22, 2024 | thestreet.comPureTech Health plcMarch 19, 2024 | msn.comPureTech announces $100M capital return through tender offerFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 1.000 callFebruary 8, 2024 | msn.com2 impressive growth stocks I’ve got my eye on in FebruaryNovember 17, 2023 | finance.yahoo.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 14, 2023 | lse.co.ukPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | finance.yahoo.comPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersAugust 29, 2023 | finanznachrichten.dePureTech Health plc - Half-Year ReportAugust 1, 2023 | msn.comPureTech bags $11.4M from U.S. Department of Defense contractAugust 1, 2023 | finance.yahoo.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeJune 21, 2023 | lse.co.ukPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | finance.yahoo.comPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersApril 29, 2023 | benzinga.comPureTech Health Stock (NASDAQ:PRTC), DividendsApril 28, 2023 | markets.businessinsider.comPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The DetailsApril 25, 2023 | bizjournals.comMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsApril 25, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesApril 20, 2023 | lse.co.ukPureTech Health's Vedanta Biosciences boasts "promising" resultsMarch 23, 2023 | proactiveinvestors.comPureTech Health remains undervalued after KarXCT deal, says brokerMarch 23, 2023 | marketwatch.comPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty DealMarch 23, 2023 | markets.businessinsider.comRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTMarch 23, 2023 | proactiveinvestors.comPureTech Health shares jump 10% on US$500mln royalty dealMarch 23, 2023 | finance.yahoo.comRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CUSIPN/A CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-65,700,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-13.25% Return on Assets-13.09% Debt Debt-to-Equity Ratio29.57 Current Ratio6.76 Quick Ratio2.51 Sales & Book Value Annual Sales£3.33 million Price / Sales184.74 Cash FlowGBX 106.22 per share Price / Cash Flow2.14 Book ValueGBX 171 per share Price / Book1.33Miscellaneous Outstanding Shares270,410,000Free FloatN/AMarket Cap£615.18 million OptionableNot Optionable Beta0.93 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 47)Founder, CEO & Exec. Director Dr. Bennett M. Shapiro (Age 78)Co-Founder & Non-Exec. Director Dr. Robert S. Langer Jr. (Age 69)Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board Mr. Stephen M. Muniz J.D. (Age 48)COO, Exec. VP of Legal & Operations, Sec. and Exec. Director Dr. Bharatt M. Chowrira (Age 53)Pres and Chief of Bus. & Strategy Key CompetitorsErgomedLON:ERGOSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDOxford Nanopore TechnologiesLON:ONTView All Competitors PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed in 2024? PureTech Health's stock was trading at GBX 194.20 at the beginning of the year. Since then, PRTC shares have increased by 16.6% and is now trading at GBX 226.50. View the best growth stocks for 2024 here. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN), Chaarat Gold (CGH), Eldorado Gold (ELD), CarMax (KMX) and Knowles (KN). How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PRTC) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.